20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications

E-ISSN： 1875-6220|8|3|207-227

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.8, Iss.3, 2011-09, pp. : 207-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Applications of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): State of the Art

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6551-6552

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6630-6642

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

By Muchow Marc Maincent Philippe Muller Rainer

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 12, 2008-12 ,pp. : 1394-1405

Informa Healthcare

Access to resources Recommend Favorite

Skin Localization of Lipid Nanoparticles (SLN/NLC): Focusing the Influence of Formulation Parameters

Current Drug Delivery, Vol. 13, Iss. 7, 2016-10 ,pp. : 1100-1110

Bentham Science Publishers

Access to resources Recommend Favorite

Ophthalmic Applications of SLN and NLC

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6676-6683

Bentham Science Publishers

Access to resources Recommend Favorite